PMC:7441777 / 3468-3601 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/7441777","sourcedb":"PMC","sourceid":"7441777","source_url":"https://www.ncbi.nlm.nih.gov/pmc/7441777","text":"an antigen for neutralizing antibody preparation as potential therapeutics (Boopathi et al., 2020).\nAnother potential drug target for","tracks":[{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T13","span":{"begin":28,"end":36},"obj":"Body_part"}],"attributes":[{"id":"A13","pred":"fma_id","subj":"T13","obj":"http://purl.org/sig/ont/fma/fma62871"},{"subj":"T13","pred":"source","obj":"LitCovid-PD-FMA-UBERON"}]},{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T39","span":{"begin":3,"end":10},"obj":"Chemical"},{"id":"T40","span":{"begin":118,"end":122},"obj":"Chemical"}],"attributes":[{"id":"A39","pred":"chebi_id","subj":"T39","obj":"http://purl.obolibrary.org/obo/CHEBI_59132"},{"id":"A40","pred":"chebi_id","subj":"T40","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"},{"subj":"T39","pred":"source","obj":"LitCovid-PD-CHEBI"},{"subj":"T40","pred":"source","obj":"LitCovid-PD-CHEBI"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"LitCovid-PD-FMA-UBERON","color":"#93ecac","default":true},{"id":"LitCovid-PD-CHEBI","color":"#ec9393"}]}]}}